Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Debie, Yana Van Audenaerde, Jonas R.M. Vandamme, Timon Croes, Lieselot Teuwen, Laure-Anne Verbruggen, Lise Vanhoutte, Greetje Marcq, Elly Verheggen, Lisa Le Blon, Debbie
Debie, Yana
Van Audenaerde, Jonas R.M.
Vandamme, Timon
Croes, Lieselot
Teuwen, Laure-Anne
Verbruggen, Lise
Vanhoutte, Greetje
Marcq, Elly
Verheggen, Lisa
Le Blon, Debbie
Citations
Altmetric:
Abstract
Description
Date
2022-03-11
Journal Title
Journal ISSN
Volume Title
Publisher
Chapter title
Publication type
Peer reviewed scientific article